news19 October 2020Da Volterra is attending the Galien Week of Innovation on October 26-30, 2020The Galien Medstartup Partnering Week is a 5 days event dedicated to exhilirating online discussions and debates focused on global…more
news14 October 2020Da Volterra is attending BIO-Europe Digital on October 26-29, 2020!BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. We look forward to virtually meeting with investors and…more
news17 September 2020Da Volterra presenting an e-poster entitled “A review of meta-analyses on the impact of antibiotics on the efficacy of immune checkpoint inhibitors and cancer patients’ survival” at the ESMO Virtual Congress.The e-poster highlights the need to develop innovative approaches to protect the intestinal microbiota of cancer patients treated with immune…more
news01 September 2020Da Volterra Announces Positive Results from a Phase 1 Clinical Trial Evaluating DAV132 in Healthy Volunteers Receiving ß-lactam Antibiotics • First clinical study evaluating the safety and efficacy of DAV132 in association with antibiotics from the ß-lactam class,…more
news24 August 2020Da Volterra is attending ChinaBio® Partnering Forum Digital on August 25-27, 2020!The event will bring together—digitally—hundreds of life science leaders for three days of productive cross-border partnering. We look forward to…more
news12 July 2020Les Echos : Comment la biotech Da Volterra veut combattre la résistance aux antibiotiquesLa biotech a mis au point un adsorbant intestinal qui capte les résidus d’antibiotiques évitant ainsi la sélection de bactéries…more
news11 June 2020Coronavirus: les autorités sanitaires alertent contre un excès de prescriptions d’antibiotiques, confirmant ainsi le besoin pour des approches préventives telles que DAV132.La Direction générale de la Santé, s’appuyant sur un avis du Haut conseil scientifique, a lancé l’alerte lundi via un…more
news08 June 2020Da Volterra is attending BIO Digital on June 8-12, 2020!The BIO International Convention is the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings…more
news04 June 2020Da Volterra’s CEO, Florence Séjourné, part of an interactive, virtual panel discussion: “Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance” during the virtual edition of the 2020 BIO International Convention.Moderator: Natalie Grover, Reporter, Endpoints News. Speakers: Oreola Donini, PhD, Chief Scientific Officer, Soligenix, Inc. Daria Hazuda, VP, Infectious Diseases…more
Non classé26 May 2020New study published in the Journal of Infection Control & Hospital Epidemiology highlights the need for prevention of CDI, especially in patients with hematological malignanciesThe Da Volterra team, along with fellow scientists, is glad to announce the publication of a new study in the…more
